Quarterly EPS Estimate For EnteroMedics Inc. (NASDAQ:ETRM) Stands At $-0.67

0

The average EPS estimate for EnteroMedics Inc. (NASDAQ:ETRM) for the three-month period quarter ended 2016-09-30 stands at $-0.67.

The EPS estimates for the stock 7 days ago was$-0.67 and for 30 days ago it was $-0.67. For 60 and 90 days ago, the stock had EPS estimates of $-0.67 and $-0.67 respectively. If you look at the latest 7 days and the prior 7 days, if you find that the stock’s EPS estimate changed 0%.

The last 7 days saw 0 upwards EPS revisions on the stock compared to 0 downward EPS revisions over the same period. In the last 30 and 60 days, the number of upward EPS estimates revisions were 0 and 0, respectively. That compared with upward EPS estimates revisions of 0 and 0 for the last 90 and 120 days, respectively.

As for the last 18 days, the number of upward and downward EPS revisions on the stock were 1 and 0 respectively.

Earnings Surprises

EnteroMedics Inc. (NASDAQ:ETRM) posted actual EPS of $-0.82 on 2016-05-05 for the quarter ended 1. That compared with the average EPS estimate for the quarter of $-0.67, based on a total of 2 EPS estimates on the stock.

As such, the EPS surprise in dollar terms per share was $-0.02 and percentage surprise was -2.5%. That works out to standard deviation of 0 if you take into account all the EPS estimates before the actual EPS report.

Quarterly Sales Estimates

The mean sales estimate for EnteroMedics Inc. (NASDAQ:ETRM) for the fiscal year 2016 is $0.295 while the median sales estimate is $0.295. The mean and median sales estimates are worked out based on the accounts of 2 analysts covering the stock for the cited fiscal year.

The highest sales estimate for EnteroMedics Inc. (NASDAQ:ETRM) is $0.39 while the lowest sales estimate is $0.2. That works out to standard deviation of 0.134%.

In the past week, 2 analysts have raised their sales estimates on the stock while 2 analysts have trimmed their sales estimates. That works out a percentage change in mean sales estimate of 0% from the past week.

In the last one month, 2 analysts have increased their sales estimates on the stock while 2 analysts have reduced their sales estimates. With that, you find that the percentage change in mean sales estimate since one month ago stands at 47.5%.

Since three months ago, 2 analysts have raised their sales estimates for EnteroMedics Inc. (NASDAQ:ETRM) and 2 have lowered their sales estimates for the stock. Therefore, the percentage change in mean sales estimate for the stock from the last three months is -47.787%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 28 times, 1 visits today)